Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening
文献类型:期刊论文
作者 | Zhang, Dan2,4,5; Han, Jie2,5,6; Lu, Wenchao2,5,6; Lian, Fulin5,6; Wang, Jun5,7; Lu, Tian5,7; Tao, Hongru5,8; Xiao, Senhao5,9; Zhang, Fengcai3,5; Liu, Yu-Chih1 |
刊名 | BIOORGANIC CHEMISTRY |
出版日期 | 2019-05-01 |
卷号 | 86页码:494-500 |
ISSN号 | 0045-2068 |
关键词 | Lysine acetylation Bromodomain Virtual screening BPTF inhibitor |
DOI | 10.1016/j.bioorg.2019.01.035 |
通讯作者 | Zhao, Chunshen() ; Luo, Cheng(cluo@simm.ac.cn) |
英文摘要 | Bromodomain PHD finger transcription factor (BPTF), a bromodomain-containing protein, plays a crucial role in the regulation of downstream gene expression through the specific recognition of lysine acetylation on bulk histones. The dysfunction of BPTF is closely involved with the development and progression of many human diseases, especially cancer. Therefore, BPTF bromodomain has become a promising drug target for epigenetic cancer therapy. However, unlike BET family inhibitors, few BPTF bromodomain inhibitors have been reported. In this study, by integrating docking-based virtual screening with biochemical analysis, we identified a novel selective BPTF bromodomain inhibitor DCB29 with the IC50 value of 13.2 +/- 1.6 mu M by homogenous timeresolved fluorescence resonance energy transfer (HTRF) assays. The binding between DCB29 and BPTF was confirmed by NMR and SPR. Molecular docking disclosed that DCB29 occupied the pocket of acetylated H4 peptide substrate and provided detailed SAR explanations for its derivatives. Collectively, DCB29 presented great potential as a powerful tool for BPTF-related biological research and further medicinal chemistry optimization. |
WOS关键词 | DOSE-ESCALATION ; BET INHIBITORS ; DOCKING ; PROTEIN ; OTX015 ; PAINS |
资助项目 | China Postdoctoral Science Foundation[2017M621571] ; National Natural Science Foundation of China[21472208] ; National Natural Science Foundation of China[81625022] ; National Natural Science Foundation of China[81430084] ; K. C. Wong Education Foundation ; Chinese Academy of Sciences[XDA12020353] ; Chinese Academy of Sciences[XDA12050401] |
WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry |
语种 | 英语 |
出版者 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
WOS记录号 | WOS:000464108100052 |
源URL | [http://119.78.100.183/handle/2S10ELR8/289989] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Zhao, Chunshen; Luo, Cheng |
作者单位 | 1.Shanghai ChemPartner Co LTD, Zhangfiang Hitech Pk, Shanghai 201203, Peoples R China 2.Pilot Natl Lab Marine Sci & Technol Qingdao, Open Studio Druggabil Res Marine Nat Prod, 1 Wenhai Rd, Qingdao 266237, Shandong, Peoples R China 3.Nanchang Univ, Sch Pharm, 461 Bayi Rd, Nanchang 330006, Jiangxi, Peoples R China 4.Guizhou Univ, Sch Pharmaceut Sci, Key Lab Guizhou Fermentat Engn & Biomed, Guizhou Engn Lab Synthet Drugs, Guiyang 550025, Guizhou, Peoples R China 5.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 6.Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 7.Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing 210023, Jiangsu, Peoples R China 8.Shanghai Univ, Sch Life Sci, 99 Shanghai Rd, Shanghai 200444, Peoples R China 9.ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Dan,Han, Jie,Lu, Wenchao,et al. Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening[J]. BIOORGANIC CHEMISTRY,2019,86:494-500. |
APA | Zhang, Dan.,Han, Jie.,Lu, Wenchao.,Lian, Fulin.,Wang, Jun.,...&Luo, Cheng.(2019).Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening.BIOORGANIC CHEMISTRY,86,494-500. |
MLA | Zhang, Dan,et al."Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening".BIOORGANIC CHEMISTRY 86(2019):494-500. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。